With wide support, Hatch files Senate bill to repeal medical device tax
Jeffrey Clark - Posted: 1/28/2015
Momentum to repeal the medical device tax is building. The Medical Device Access & Innovation Protection Act, a bipartisan bill to repeal the 2.3% excise tax on medical devices, was introduced in the Senate on Tuesday by Senator Orrin Hatch (R-UT), a[...]
Valeant CEO defends business after losing Allergan to Actavis
Jeffrey Clark - Posted: 1/22/2015
Valeant CEO Mike Pearson claims the company is on a mission to prove allegations against the business model during the Allergan acquisition are not true.  In an interview with Financial Times, Pearson remarks: Part of our thesis was that no one else [...]
Obama supports personalized medicine, life sciences in SOTU speech
Jeffrey Clark - Posted: 1/21/2015
Last night brought President Barack Obamas State of the Union address, during which he announced a provision specific to the life sciences industry. From the SOTU, Obama will ask Congress for funds to launch a precision medicine initiative to acceler[...]
Ariad CEO Harvey Berger at JPMHC
Jeffrey Clark - Posted: 1/21/2015
Ariad CEO Harvey Berger talks commercial success and the companys new cancer drug.
Orexigen CEO Mike Narachi at JPMHC
Jeffrey Clark - Posted: 1/20/2015
Orexigen CEO Mike Narachi talks about its recent obesity drug launch.
The lighter side of JPM Healthcare conference
Jeffrey Clark - Posted: 1/15/2015
Funny thing about the JP Morgan event is youll never see this many suits in SF any other time of the year #JPM15 — Dave Saunders (@davesaunders) January 12, 2015 Cute. #jpm15 — Chris Seper (@chrisseper) January 14, 2015 S[...]
JPMHC: 23andMe CEO Anne Wojcicki talks data
Jeffrey Clark - Posted: 1/15/2015
23andMe CEO Anne Wojcicki is married to Sergey Brin, founder of Google. And, the company aspires to a similar path, hoping to dominate the data-driven business model for the life sciences industry. The journey started with consumer-based genetic test[...]
Convicted Imclone CEO Sam Waksal reappears at JPMHC
Jeffrey Clark - Posted: 1/15/2015
In a compelling interview with CNBC, former Imclone CEO Sam Waksal reveals how the insider trading scandal has impacted his life and his involvement with his new company, Kadmon.
JPMHC: Actavis CEO Brett Saunders is a rock star
Jeffrey Clark - Posted: 1/15/2015
Actavis CEO Brett Saunders now leads one of the biggest and most talked about companies in the life sciences industry, after winning the battle with Valeant to acquire Allergan in late 2014.  Today, he speaks with CNBC at JP Morgan Healthcare confere[...]
JPMHC: Celgene CEO Robert Hugin
Jeffrey Clark - Posted: 1/14/2015
As usual, Celgene kicked off the 2015 JPMorgan Healthcare conference in San Francisco.  Celgene CEO Robert Hugin talks pipeline, plans for 2015 and his goal to reach $20B in revenue by 2020.
JPMHC: Biogen Idec CEO George Scangos
Jeffrey Clark - Posted: 1/14/2015
JPMHC: Biogen Idec CEO George Scangos
JPMHC: Agios CEO David Schenkein
Jeffrey Clark - Posted: 1/13/2015
Agios CEO Dr. David Schenkein explains a cancers metabolism, and the companys priorities for 2015.
JPMHC: Merck CEO Ken Frazier
Jeffrey Clark - Posted: 1/13/2015
JPMorgans Healthcare conference, the annual life sciences carnival, is underway in San Francisco. Well have updates, interviews and presentations all week. First up, Merck CEO Ken Frazier
The Woodstock of Life Sciences, JPMHC gets underway in San Francisco
Jeffrey Clark - Posted: 1/12/2015
The JPMorgan health care conference starts today in San Francisco, the annual pilgrimage for life sciences CEOs, their deal making teams and investors. The conference got off to a quick start with Shire purchasing NJ-based NPS Pharmaceuticals for $5.[...]
As expected, medical device tax repeal introduced in Congress
Jeffrey Clark - Posted: 1/12/2015
Ever since the Republicans seized control of Congress, the life sciences industry has anticipated an early January effort to repeal certain components of the Affordable Healthcare Act, specifically the medical device tax. Late last week, a bipartisan[...]
Suneris CEO touts new technology to instantly stop bleeding
Jeffrey Clark - Posted: 1/9/2015
Vetigel is a plant-based gel that stops internal and external bleeding in seconds. Suneris CEO Joe Landolina is in his early 20′s and speaks with CNBC about the innovation. The product is not yet FDA approved and will be launched first with an [...]
JPMorgan conference under spotlight
Jeffrey Clark - Posted: 1/8/2015
CNBC discusses the availability of public information at industry conferences such as next weeks JP Morgan Healthcare conference. The debate goes like this. Companies share lots of information at these events. Most is shared in a formal presentation [...]
2014 approvals and deals dominate the New Year chatter
Jeffrey Clark - Posted: 1/7/2015
Next week at the JPMorgan Healthcare Conference, everyone will be talking M&A.  Specifically, they will reflect on the viral M&A activity of 2014, which shattered all the records. In the wake of Actavis $94B shopping spree which included Allergan and[...]
Medtronic shareholders vote in favor of Covidien deal
Jeffrey Clark - Posted: 1/6/2015
In a small meeting at the Hyatt Regency in downtown Minneapolis, Medtronic  shareholders approved one of the largest deals in medical device history, green-lighting the company’s $43 billion acquisition of Covidien.  The approval means that the trans[...]
Novartis CEO talks research and pipeline strategy
Jeffrey Clark - Posted: 1/6/2015
Novartis CEO Joe Jimenez talks R&D and pipeline strategy with CNBC.
Gilead CEO dominates 2014 Best of lists
Jeffrey Clark - Posted: 1/5/2015
This years best CEO in the life sciences industry may be a short discussion.  While dominating the platform, Gilead Sciences John Martin is representing the life sciences industry well on 2014 lists ranking best performing CEOs.  Harvard Business Rev[...]
Looking forward: Novo plans in 2015 for eventual CEO transition
Jeffrey Clark - Posted: 12/30/2014
Novo Nordisk has been one of the best performing companies in the life sciences industry over the past few years.  Where others faltered, Novo Nordisk has risen to new heights of financial and corporate performance.  The company has the best growth c[...]
Former Army CEO leading the way in promotion of veteran hiring
Jeffrey Clark - Posted: 12/30/2014
Led by its West Point-educated CEO, Johnson & Johnson is promoting the hiring of veterans across the life sciences industry.  And going even further, Alex Gorsky has made it a priority to advance the cause of promoting veterans to employers across al[...]
MassDevice: Medical device leaders share thoughts on 2014
Jeffrey Clark - Posted: 12/30/2014
As 2015 winds to a close, MassDevice has a great article offering the opinions of various medical device CEOs on the year that was in 2014.  Included in the virtual roundtable are Mike Mussallem from Edwards Life Sciences and Brian Concannon from Hae[...]
Amgen Oncology gets our vote for best video of 2014
Jeffrey Clark - Posted: 12/29/2014
The Oncology team at Amgen released this video earlier this year, likely after it was debuted at ASCO . Like many great corporate branding videos, it has been buried in the bowels of Youtube and has been seen by only a few.  It should be seen by ever[...]
With wide support, Hatch [...]
Momentum to repeal the medical device tax is building.
Valeant CEO defends busin[...]
Valeant CEO Mike Pearson claims the company is on a mission to prove allegations against the busines[...]
Ariad CEO Harvey Berger a[...]
Ariad CEO Harvey Berger talks commercial success and the company’s new cancer drug.
Orexigen CEO Mike Narachi[...]
Orexigen CEO Mike Narachi talks about its recent obesity drug launch.
JPMHC: 23andMe CEO Anne W[...]
23andMe CEO Anne Wojcicki is married to Sergey Brin, founder of Google. And, the company aspires to [...]